Adjunctive hydrodissection of the bare area of liver during percutaneous thermal ablation of sub-cardiac hepatic tumours.
Bare area of the liver
Heart
Hydrodissection
Thermal ablation
Journal
Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
pubmed:
27
3
2020
medline:
22
6
2021
entrez:
27
3
2020
Statut:
ppublish
Résumé
To report the technique of hydrodissection of the sub-diaphragmatic bare area of the liver, in order to protect the diaphragm/heart during percutaneous thermal ablation (PTA) of sub-cardiac hepatic tumours. Between January 2016 and December 2018, five patients (four female, one male; mean age 56.2 years) with five sub-cardiac liver tumours (two hepatocellular carcinoma, three metastases; mean size 39 mm) abutting the bare area (segments II/IVA) with expected ablation zones ≤ 5 mm from the myocardium were treated with PTA and adjunctive hydrodissection. Time to perform hydrodissection, distance between superior hepatic and diaphragmatic/pericardial surfaces before and after hydrodissection, ablation efficacy, complications, and local tumour progression (LTP) at last imaging follow-up were recorded. Technical feasibility was 100%, with mean hydrodissection-volume of 126 ml (range 80-200 ml) and median hydrodissection-time of 9 min (range 8-45 min). Liver-diaphragmatic and liver-pericardial distance increased, respectively, from 2.4 mm (range 0-8 mm) to 10.8 mm (range 6-19 mm) and from 4 mm (range 1-10 mm) to 12.6 mm (range 8-20 mm) post-hydrodissection. All procedures were performed at full-power with complete tumour ablation and without complications (including peri-procedural haemodynamic/electrocardiographic disturbances, pericardial effusion and diaphragmatic hernia) or evidence of LTP at mean 12.2-month (range 1-26 month) follow-up. Hydrodissection of the sub-diaphragmatic bare area of the liver is technically feasible and may potentially optimize safety PTA of sub-cardiac hepatic tumours.
Identifiants
pubmed: 32211949
doi: 10.1007/s00261-020-02463-0
pii: 10.1007/s00261-020-02463-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3352-3360Commentaires et corrections
Type : CommentIn
Références
Garnon J, Cazzato RL, Caudrelier J, Nouri-Neuville M, Rao P, Boatta E, Ramamurthy N, Koch G, Gangi A. Adjunctive thermoprotection during percutaneous thermal ablation procedures: review of current techniques. Cardiovasc Intervent Radiol. 2019;42(3):344–357. https://doi.org/10.1007/s00270-018-2089-7
doi: 10.1007/s00270-018-2089-7
pubmed: 30310986
Rhim H, Lim HK. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: the value of artificial ascites. Abdom Imaging. 2009 May-Jun;34(3):371–80. https://doi.org/10.1007/s00261-008-9408-4 .
Bhagavatula SK, Chick JF, Chauhan NR, Shyn PB. Artificial ascites and pneumoperitoneum to facilitate thermal ablation of liver tumors: a pictorial essay. Abdom Radiol (NY). 2017 Feb;42(2):620–630. https://doi.org/10.1007/s00261-016-0910-9.
doi: 10.1007/s00261-016-0910-9
pubmed: 27665483
Kim S, Kim TU, Lee JW, Lee TH, Lee SH, Jeon TY, Kim KH. The perihepatic space: comprehensive anatomy and CT features of pathologic conditions. Radiographics.2007 Jan-Feb;27(1):129–43.
Coffin A, Boulay-Coletta I, Sebbag-Sfez D, Zins M. Radioanatomy of the retroperitoneal space. Diagn Interv Imaging. 2015 Feb;96(2):171–86. https://doi.org/10.1016/j.diii.2014.06.015 .
doi: 10.1016/j.diii.2014.06.015
pubmed: 25547251
Carberry GA, Smolock AR, Cristescu M, Wells SA, Ziemlewicz TJ, Lubner MG,Hinshaw JL, Brace CL, Lee FT Jr. Safety and Efficacy of Percutaneous Microwave Hepatic Ablation Near the Heart. J Vasc Interv Radiol. 2017 Apr;28(4):490–497. https://doi.org/10.1016/j.jvir.2016.12.1216 .
doi: 10.1016/j.jvir.2016.12.1216
pubmed: 28190707
Schullian P, Putzer D, Laimer G, Levy E, Bale R. Feasibility, safety, and long-term efficacy of stereotactic radiofrequency ablation for tumors adjacent to the diaphragm in the hepatic dome: a case-control study. Eur Radiol. 2019 Sep 5. https://doi.org/10.1007/s00330-019-06399-y .
doi: 10.1007/s00330-019-06399-y
pubmed: 31489472
pmcid: 6957558
Smolock AR, Lubner MG, Ziemlewicz TJ, Hinshaw JL, Kitchin DR, Brace CL, Lee FT Jr. Microwave ablation of hepatic tumors abutting the diaphragm is safe and effective. AJR Am J Roentgenol. 2015 Jan;204(1):197–203. https://doi.org/10.2214/ajr.14.12879 .
doi: 10.2214/ajr.14.12879
pubmed: 25539257
pmcid: 6560625
Kang TW, Rhim H, Kim EY, et al. Percutaneous radiofrequency ablation for the hepatocellular carcinoma abutting the diaphragm: assessment of safety and therapeutic efficacy. Korean J Radiol. 2009;10(1):34–42. https://doi.org/10.3348/kjr.2009.10.1.34
doi: 10.3348/kjr.2009.10.1.34
pubmed: 19182501
pmcid: 2647171
Kwan J, Appuhamy C, Lim GHT, Huang IKH, Quek L, Pua U. Safety and Efficacy of Percutaneous Thermal Ablation of Juxta-Cardiac Hepatic Tumours. Cardiovasc Intervent Radiol. 2018 Jun;41(6):920–927. https://doi.org/10.1007/s00270-018-1938-8 . Epub 2018 Mar 26.
doi: 10.1007/s00270-018-1938-8
pubmed: 29582128
Kwon JH, Won JY, Han K, Han S, Kim D, Kim H, Kim GM, Kim MD, Lee DY. Safety and Efficacy of Percutaneous Cryoablation for Small Hepatocellular Carcinomas Adjacent to the Heart. J Vasc Interv Radiol. 2019 Aug;30(8):1223–1228. https://doi.org/10.1016/j.jvir.2018.12.030 . Epub 2019 Apr 5.
doi: 10.1016/j.jvir.2018.12.030
pubmed: 30956074
Cha DI, Kang TW, Song KD, Lee MW, Rhim H, Lim HK, Sinn DH, Kim K. Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure. Eur Radiol. 2019 May;29(5):2706–2715. https://doi.org/10.1007/s00330-018-5868-2 . Epub 2018 Nov 30.
doi: 10.1007/s00330-018-5868-2
pubmed: 30506222
Saito T, Chiba T, Ogasawara S, et al. Fatal Diaphragmatic Hernia following Radiofrequency Ablation for Hepatocellular Carcinoma: A Case Report and Literature Review. Case Rep Oncol. 2015;8(2):238–245. Published 2015 May 28. https://doi.org/10.1159/000431310
Silverman ER, Lai YH, Osborn IP, Yudkowitz FS. Percutaneous radiofrequency ablation of hepatocellular lesions in segment II of the liver: a risk factor for cardiac tamponade. J Clin Anesth. 2013 Nov;25(7):587–90. https://doi.org/10.1016/j.jclinane.2013.04.014 .
doi: 10.1016/j.jclinane.2013.04.014
pubmed: 23988803
Chung MW, Ha SY, Choi JH, Park HJ, Myung DS, Cho SB, Lee WS, Kim JW, Oh HH, Joo YE. Cardiac tamponade after radiofrequency ablation for hepatocellular carcinoma: Case report and literature review. Medicine (Baltimore). 2018 Dec;97(49):e13532. https://doi.org/10.1097/md.0000000000013532 .
doi: 10.1097/md.0000000000013532
pubmed: 30544457
pmcid: 6310525
Patel IJ, Davidson JC. Standards of Practice Committee, with Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Endorsement. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol. 2012; 23(6):727–36
Campbell C, Lubner MG, Hinshaw JL, Muñoz del Rio A, Brace CL. Contrast media-doped hydrodissection during thermal ablation: optimizing contrast media concentration for improved visibility on CT images. AJR Am J Roentgenol. 2012 Sep;199(3):677–82.
Sato R, Aramaki T, Yoza K, Iwai K, Moriguchi M, Asakura K, Endo M, Ito T. “Direct MPR”: A Useful Tool for Oblique CT Fluoroscopy-Assisted Puncture. Cardiovasc Intervent Radiol. 2017 Aug;40(8):1261–1266. https://doi.org/10.1007/s00270-017-1642-0 .
doi: 10.1007/s00270-017-1642-0
pubmed: 28439625
Garnon J, Koch G, Caudrelier J, Ramamurthy N, Auloge P, Cazzato RL, Gangi A. Hydrodissection of the Gallbladder Bed: A Technique for Ablations Located Close to the Gallbladder. Cardiovasc Intervent Radiol. 2019 Jul;42(7):1029–1035. https://doi.org/10.1007/s00270-019-02218-5 .
doi: 10.1007/s00270-019-02218-5
pubmed: 30963191
Garnon J, Koch G, Caudrelier J, Boatta E, Rao P, Nouri-Neuville M, Ramamurthy N, Cazzato RL, Gangi A. Hydrodissection of the Retrohepatic Space: A Technique to Physically Separate a Liver Tumour from the Inferior Vena Cava and the Ostia of the Hepatic Veins. Cardiovasc Intervent Radiol. 2019 Jan;42(1):137–144. https://doi.org/10.1007/s00270-018-2105-y .
doi: 10.1007/s00270-018-2105-y
pubmed: 30386883
Brennan DD, Ganguli S, Brecher CW, Goldberg SN. Thinking outside the abdominal box: safe use of the epipericardial fat pad window for percutaneous radiofrequency ablation of hepatic dome tumors. J Vasc Interv Radiol. 2008 Jan;19(1):133–6. https://doi.org/10.1016/j.jvir.2007.08.023 .
doi: 10.1016/j.jvir.2007.08.023
pubmed: 18192479
Qi H, Zhang H, Wan C, Xie L, Song Z, Fan W. CT-guided microwave ablation through the lungs for treating liver tumors near the diaphragm. Oncotarget. 2017;8(45):79270–79278. Published 2017 Apr 26. https://doi.org/10.18632/oncotarget.17422
Raman SS, Aziz D, Chang X, Sayre J, Lassman C, Lu D. Minimizing diaphragmatic injury during radiofrequency ablation: efficacy of intraabdominal carbon dioxide insufflation. AJR Am J Roentgenol. 2004;183:197–200.
doi: 10.2214/ajr.183.1.1830197
Knuttinen MG, Van Ha TG, Reilly C, Montag A, Straus C. Unintended thermal injuries from radiofrequency ablation: organ protection with an angioplasty balloon catheter in an animal model. J Clin Imaging Sci. 2014;4:1. Published 2014 Jan 30. https://doi.org/10.4103/2156-7514.126018
Lyu T, Wang X, Su Z, et al. Irreversible electroporation in primary and metastatic hepatic malignancies: A review. Medicine (Baltimore). 2017;96(17):e6386. https://doi.org/10.1097/md.0000000000006386
doi: 10.1097/md.0000000000006386
pubmed: 28445252
pmcid: 5413217
Abe T, Amano H, Takechi H, Fujikuni N, Sasada T, Yoshida M, Yamaki M, Nakahara M, Noriyuki T. Late-onset diaphragmatic hernia after percutaneous radiofrequency ablation of hepatocellular carcinoma: a case study. Surg Case Rep. 2016 Dec;2(1):25. https://doi.org/10.1186/s40792-016-0148-3 .
doi: 10.1186/s40792-016-0148-3
pubmed: 26976615
pmcid: 4791441